Dergiler / Turkish Journal of Medical Sciences / 2022 / Cilt: 52 - Sayı: 3

Hydroxychloroquine induces endothelium-dependent and endothelium-independent relaxation of rat aorta

Sayfa
848–857
Yayın Tarihi
2022-11-06
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

We strongly suggest that $Ca^{2+}$ channel inhibition is involved at concentrations of 10-5 and 10-4 M, as well as NO.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/aim: Hydroxychloroquine (HCQ) is an antimalarial that is widely used in the management of rheumatoid arthritis and other autoimmune diseases.
📊
Temel Bulgular & Veri:HCQ-induced relaxations were tested in the presence of the nitric oxide synthase inhibitor, nitro-L-arginine methyl ester (L-NAME, 100 mM); the cyclooxygenase enzyme inhibitor, indomethacin (10 mM); the calcium $(Ca^{2+})$ ion channel blocker, nilvadipine (10 μM); and the K+ ion channel inhibitors, tetraethylammonium (1 mM), glibenclamide (10 mM), 4-aminopyridine (1 mM), and barium chloride (30 mM).
💡
Sonuç & Katkı:We strongly suggest that $Ca^{2+}$ channel inhibition is involved at concentrations of 10-5 and 10-4 M, as well as NO.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Background/aim: Hydroxychloroquine (HCQ) is an antimalarial that is widely used in the management of rheumatoid arthritis and other autoimmune diseases. In this study, we aimed to examine the vascular effects of HCQ on rat aorta (RA). Materials and methods: The RA rings were suspended in isolated organ baths and tension was recorded isometrically. HCQ-induced relaxations were tested in the presence of the nitric oxide synthase inhibitor, nitro-L-arginine methyl ester (L-NAME, 100 mM); the cyclooxygenase enzyme inhibitor, indomethacin (10 mM); the calcium $(Ca^{2+})$ ion channel blocker, nilvadipine (10 μM); and the K+ ion channel inhibitors, tetraethylammonium (1 mM), glibenclamide (10 mM), 4-aminopyridine (1 mM), and barium chloride (30 mM). The effect of HCQ on $Ca^{2+}$ channels was examined using $Ca^{2+}$-free Krebs solution, and adding calcium chloride $(CaCl_2, 10^{-5}– 10^{-2} M)$ cumulatively to baths incubated with HCQ. Results: Removing the endothelium resulted in less relaxation of RA rings compared to endothelium-intact rings (p < 0.05). The effect of endothelium was supported by using L-NAME where HCQ produced-vasorelaxation was decreased (p < 0.05). The contraction of vascular rings was inhibited to a significant degree following the addition of $CaCl_2$, PE, or KCl on HCQ-incubated RA rings (p < 0.05). The incubation of the RA rings with the $Ca^{2+}$ channel blocker, the $K^+$ channel blockers, and the COX inhibitor, indomethacin did not significantly affect vascular relaxation induced by HCQ. Conclusion: HCQ produced relaxation of RA rings. The relaxation mechanism differs according to the concentration of HCQ. At concentrations of 10-6 and 10-5 M, the relaxation is endothelium-dependent and mediated by NO. We strongly suggest that $Ca^{2+}$ channel inhibition is involved at concentrations of 10-5 and 10-4 M, as well as NO.

🔖

Bu Makaleye Atıf Yap

PARLAR, A., ÇAM, S. A., ANDAÇ, A. C., OMAR, I. A., UYSAL, F., ARSLAN, S. O., DOĞAN, M. F., YILDIZ, O. (2022). Hydroxychloroquine induces endothelium-dependent and endothelium-independent relaxation of rat aorta. Turkish Journal of Medical Sciences, Cilt: 52 - Sayı: 3, 848–857. https://ajindex.com/articles/609261

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Wallace DJ, Gudsoorkar VS, Weisman MH, Venuturupalli SR. New insights into mechanisms of therapeutic effects of antimalarial agents in SLE. Nature Reviews Rheumatology 2012; 8 (9): 522–533. doi: 10.1038/nrrheum.2012.106 2. Wallace DJ. The history of antimalarials. Lupus 1996; 5 (SUPPL. 1): 2–3. 3. Schrezenmeier E, Dörner T. Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nature Reviews Rheumatology 2020; 16 (3): 155– 166. doi: 10.1038/s41584-020-0372-x 4. Ben-Zvi I, Kivity S, Langevitz P, Shoenfeld Y. Hydroxychloroquine: From malaria to autoimmunity. Clinical Reviews in Allergy & Immunology 2012; 42 (2): 145–153. doi: 10.1007/s12016-010- 8243-x 5. Rempenault C, Combe B, Barnetche T, Gaujoux-Viala C, Lukas C et al. Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: A systematic review and meta-Analysis. Annals of the Rheumatic Diseases 2018; 77 (1): 98–103. doi:10.1136/annrheumdis-2017-211836 6. Mathieu S, Pereira B, Tournadre A, Soubrier M. Cardiovascular effects of hydroxychloroquine: a systematic review and metaanalysis. Annals of the Rheumatic Diseases 2018; 77 (10): e65. doi: 10.1136/annrheumdis-2017-212571 7. Bengtsson C, Andersson SE, Edvinsson L, Edvinsson ML, Sturfelt G et al. Effect of medication on microvascular vasodilatation in patients with systemic lupus erythematosus. Basic & Clinical Pharmacology & Toxicology 2010; 107 (6): 919–924. doi: 10.1111/j.1742-7843.2010.00604.x 8. Godo S, Shimokawa H. Endothelial Functions. Arteriosclerosis, Thrombosis, and Vascular Biology 2017; 37 (9): e108–114. doi: 10.1161/ATVBAHA.117.309813 9. Abiose AK, Grossmann M, Tangphao O, Hoffman BB, Blaschke TF. Chloroquine-induced venodilation in human hand veins. Clinical Pharmacology & Therapeutics 1997; 61 (6): 677–683. doi: 10.1016/S0009-9236(97)90103-X 10. Adegunloye BJ, Sofola OA, Coker HAB. Relaxant effects of mefloquine on vascular smooth muscle in vitro. European Journal of Clinical Pharmacology 1993; 45 (1): 85–88. doi: 10.1007/BF00315355 11. Aziba PI, Okpako DT. Effects of chloroquine on smooth muscle contracted with noradrenaline or high-potassium solutions in the rat thoracic aorta. Journal of Smooth Muscle Research 2003; 39 (3): 31–37. doi: 10.1540/jsmr.39.31 12. Dogan MF, Yildiz O, Arslan SO, Ulusoy KG. Potassium channels in vascular smooth muscle: a pathophysiological and pharmacological perspective. Fundamental & Clinical Pharmacology 2019; 33 (5): 504–523. d